Which of the following is NOT a goal of aerosol therapy?

All of the following are advantages of delivering drugs via inhalation EXCEPT?

Which of the following describes a disadvantage of delivering medications via aerosol?

When an aerosol particle CANNOT navigate around a branching of the airway and is deposited onto the oncoming airway wall, it has been affected by _____.

Which of the following defines aerosol deposition?

The aerosol delivery device that is most capable of creating very stable aerosols is the _____.

Which of the following describes the term penetration?

Which term describes an aerosol particle that is unable to negotiate a turn within the tracheobronchial tree and that ultimately deposits on the area of bifurcation of the airways?

A medicated aerosol can be described as a _____.

The depth to which the aerosol particle reaches within the lung is known as _____.

Which of the following particle sizes provides the best opportunity for deposition of medication into the lower airways?

Deposition of aerosols into the nasal cavity is best achieved with which of the following aerosol particle sizes?

The particle size that allows for best penetration of medication to the lower airways upon inhalation of a medicated aerosol is _____.

What is the name of the amount of medication that remains in the SVN after nebulization?

Medications such as Afrin® are formulated to generate aerosol particle sizes of _____ microns so that they will be deposited in the nasopharynx, where their action is more desired.

Which of the following factors affect drug delivery via the inhalation route? I. The properties of the drug being aerosolized. II. The device used to generate the aerosol. III.The characteristics of the airway. IV.The patient’s breathing pattern.

When an inspiratory breath hold is used with an optimal breathing pattern, which of the following will happen?

Which is NOT considered a bronchodilator?

Secretions can be broken down by administering which type of the following agents?

Which of the following is NOT a corticosteroid?

Which of the following is NOT an inhaled antimicrobial agent?

Aerosolized medications can be delivered with which of the following? I. A BAN II. An MDI with a holding chamber III. A HEART® nebulizer IV. A DPI

After inhaled corticosteroid administration, how can the patient prevent an opportunistic oral infection?

Which of the following is NOT an advantage of using a spacer or holding chamber?

If a spacer is NOT available for use with an MDI, how should you instruct the patient to use the inhaler?

If a patient is taking several medications with an MDI, which drug should the patient be instructed to take first?

A 3-year-old is being discharged. You are asked to select an aerosol device. Which of the following is most appropriate?

A patient should be instructed to activate the medication in an MDI in which of the following manners?

When an MDI has NOT been used for 2 weeks, which of the following should a patient be instructed to do?

What is the difference between a spacer and a holding chamber?

What instructions to a patient during administration of an aerosol medication will result in the best aerosol deposition? I. After inhalation, hold the breath for 10–15 seconds. II. Inhale as quickly as possible. III. Take a slow, deep breath. IV. Exhale as quickly as possible.

Which MDI propellant was replaced due to ozone depletion?

If a patient is required to use an MDI but does NOT have a spacer or holding chamber, which would be an appropriate technique for the patient to follow during medication administration? I. Have the patient hold the inhaler two finger widths from the mouth. II. Have the patient begin to breathe in slowly just before depressing the canister. III. Have the patient breathe in as slowly and fully as possible. IV. At end inspiration, have the patient hold a breath for 10–15 seconds.

All of the following are required for optimal deposition EXCEPT _____.

Aerosol particle size can be improved by which of the following factors, leading to an increase in aerosol delivery to the patient? I. Flow rates of 6–8 l/min. II. A dead volume of 3–6 ml. III. A fill volume of 4–6 ml

Which of the following is the most efficient in reducing the amount of wasted medication during exhalation?

Which of the following is NOT a side effect associated with the administration of albuterol?

A patient diagnosed with status asthmaticus has already received two treatments with an SVN. You are called in to administer a bronchodilator to the patient. What device would you recommend?

How do DPIs deliver aerosolized medication to the lungs?

You have been ordered to administer a DPI to a patient. Which of the following criteria would you need to assess to make sure the patient can use the device? I. Inspiratory flow of at least 40 l/m. II. Patient’s mental status. III. Neuromuscular weakness. IV. Patient’s ability to follow instructions.

All of the following are a disadvantage for DPIs EXCEPT _____.

The HandiHaler® device uses which long-acting anticholinergic agent?

Which of the following devices would be most appropriate for administration of a bronchodilator treatment to a comatose patient?

Which of the following is FALSE concerning MDI administration to an intubated and mechanically ventilated patient?

Which of the following is FALSE concerning administering a nebulizer treatment to an intubated and mechanically ventilated patient?

You have employed a breath hold with each actuation of an MDI to a patient who is intubated and mechanically ventilated. Which of the following should you assess due to the extended inspiratory time?

Which of the following should NOT be done when giving an SVN during mechanical ventilation?

When the inspiratory time is prolonged too long during aerosol delivery, which of the following parameters on the mechanical ventilator should be monitored?

What is the recommended external gas source flow setting for powering an SVN?

a goal of aerosol therapy is to decrease mobilization of secretions.

a liquid or solid drug suspended in a carrier gas is called a medicated aerosol.

When an aerosol particle falls out of suspension, it is called deposition.

There is an amount of volume in a nebulizer that never gets nebulized is called dead volume.

1-5 microns is a particle size range that is best for deposition of medication into the lower airways.

corticosteroids is a type of drug may be used to control asthma and prevent an asthma attack.

Mucolytics are a type of medication that breaks down secretions.

What is the difference between a holding chamber and a spacer?

When asked to deliver a continuous nebulizer treatment, what type of nebulizer should you choose?

Without a propellant, the patient has to generate the inspiratory flow to receive the medication. Which type of delivery device depends upon the patient’s ability to generate good inspiratory flow?

An aerosol can be either a liquid or a solid suspended in a gas.

Humidifying gas is a goal of aerosol therapy.

Aerosols can be used to deliver medications to the respiratory tract.

Aerosols will NOT help to improve the mobilization of secretions.

Delivering a consistent, precise dose with a medicated aerosol is relatively easy.

A medicated aerosol is a suspension of a solid or liquid drug in a carrier gas.

Stability refers to the ability of an aerosol to remain in suspension.

Inertial impaction occurs when an aerosol particle loses the ability to negotiate a turn.

With poor technique, aerosol particles may be deposited mostly in the oropharynx.

The depth within the lungs that is reached by an aerosol is referred to as stability.

Microns are the unit of measurement for aerosol particle size.

Aerosol particle sizes in the 10–15 micron range have their deposition in the upper airways.

Aerosol particles that are less than 0.5 microns are the most desired for deposition in the lower airways.

The desired range for particles to deposit in the lower airways is 1–5 microns.

Dead volume is the amount of medication or solution that is readily nebulized.

A breath hold does NOT affect deposition of medicated aerosols.

For penetration and deposition to the lower airways, turbulent inspiratory flow is recommended.

Nasal sprays are NOT considered medicated aerosols.

It is NOT recommended to conduct metered-dose inhaler (MDI) therapy with the use of a spacer.

A holding chamber is different from an ordinary spacer.

Ultrasonic nebulizers are very efficient.

The HEART® nebulizer can be used for continuous nebulizer therapy.

Spiriva® is prepared as a dry-powder inhaler.

DPIs can be used with ALL patients.

Medicated aerosols can be delivered to patients who are intubated and mechanically ventilated.

Infectious pathogens can be transmitted via bioaerosols.

The guidelines for the treatment and management of Covid-19 patients is static and will remain static.